Results 191 to 200 of about 305,335 (274)

An APC Trap? Privilege and the Perception of Reasonableness in Open Access Publishing

Melissa H. Cantrell, Jennifer A. Mezick, Matthew Estill, Rachel Caldwell, Lauren B. Collister   +4 more
openalex   +1 more source

TV STUDIES FOR ALL? ON OPEN ACCESS AND PUBLISHING IN TV AND MEDIA STUDIES

, 2019
Tobias Steiner
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Open Access Publishing of Textbooks and Guidelines for Otolaryngologists in Developing Countries. [PDF]

OTO Open, 2019
Fagan JJ.
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

What is open-access publishing and what it means for the forensic enterprise. [PDF]

Forensic Sci Int Synerg, 2019
Houck MM, Horsman G, Sauzier G, Bidmos M.   +3 more
europepmc   +1 more source

Open Access Publishing today: what scientists do and why

, 2011
Sünje Dallmeier-Tiessen, Bettina Goerner, Robert Darby, Jenni Hyppoelae, P. Igo-Kemenes, Deborah Kahn, Simon Lambert, Anja Lengenfelder, Chris Leonard, S. Mele, Malgorzata Nowicka, Panayiota Polydoratou, David Ross, Sergio Ruiz-Pérez, Ralf Schimmer, Mark Swaisland, Wim van der Stelt   +16 more
openalex   +1 more source

Putting theory into action: Students seeking experience with peer-reviewed open access publishing

, 2017
Suzanne Jay
openalex   +1 more source

Focus: Scholarly Publishing and Open Access [PDF]

, 2009
Gerard van Trier
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source